<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Frundt O</submitter><funding>Prof. Dr. Klaus Thiemann Stiftung</funding><pagination>736</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10216485</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(5)</volume><pubmed_abstract>Data on the use of device-aided therapies (DATs) in people with Parkinson's disease (PwP) are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application frequency and type of DAT in a larger, nationwide, cross-sectoral PwP sample in Germany; (2) analyzed the frequency of symptoms indicative for advanced PD (aPD) and need for DAT amongst the remaining patients and (3) compared the most bothersome symptoms and need for professional long-term care (LTC) of patients with and without suspected aPD. Data from 1269 PwP were analyzed. In total, 153 PwP (12%) received DAT, mainly deep brain stimulation (DBS). Of the remaining 1116 PwP without DAT, >50% fulfilled at least one aPD criterion. Akinesia/rigidity and autonomic problems were most bothersome for PwP with and witho</pubmed_abstract><journal>Brain sciences</journal><pubmed_title>Device-Aided Therapies in Parkinson's Disease-Results from the German Care4PD Study.</pubmed_title><pmcid>PMC10216485</pmcid><funding_grant_id>no grant number available</funding_grant_id><pubmed_authors>Mai T</pubmed_authors><pubmed_authors>Hanff AM</pubmed_authors><pubmed_authors>Mohl A</pubmed_authors><pubmed_authors>Frundt O</pubmed_authors><pubmed_authors>Amouzandeh A</pubmed_authors><pubmed_authors>Kruger R</pubmed_authors><pubmed_authors>Buhmann C</pubmed_authors><pubmed_authors>Sudmeyer M</pubmed_authors><pubmed_authors>Kirchner C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Device-Aided Therapies in Parkinson's Disease-Results from the German Care4PD Study.</name><description>Data on the use of device-aided therapies (DATs) in people with Parkinson's disease (PwP) are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application frequency and type of DAT in a larger, nationwide, cross-sectoral PwP sample in Germany; (2) analyzed the frequency of symptoms indicative for advanced PD (aPD) and need for DAT amongst the remaining patients and (3) compared the most bothersome symptoms and need for professional long-term care (LTC) of patients with and without suspected aPD. Data from 1269 PwP were analyzed. In total, 153 PwP (12%) received DAT, mainly deep brain stimulation (DBS). Of the remaining 1116 PwP without DAT, >50% fulfilled at least one aPD criterion. Akinesia/rigidity and autonomic problems were most bothersome for PwP with and witho</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T19:30:16.516Z</modification><creation>2025-04-04T19:30:16.516Z</creation></dates><accession>S-EPMC10216485</accession><cross_references><pubmed>37239208</pubmed><doi>10.3390/brainsci13050736</doi></cross_references></HashMap>